Aspira Pathlab & Diagnostics Limited (ASPIRA) Share Price
BSE · Healthcare · Diagnostics & Research · ISIN INE500C01017
Key metrics
- Market Cap
- ₹94 Cr
- P/E Ratio
- 1,830
- EPS
- -0.45
- Book Value
- 11.88
- P/B Ratio
- 7.7
- ROE
- 0.42%
- ROCE
- -0.48%
- Debt / Equity
- 0.27
- Net Margin
- 0.21%
- Revenue Growth
- 13.56%
- Profit Growth
- -97.52%
- Dividend Yield
- —
- 52W High
- ₹135.88
- 52W Low
- ₹49.00
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Aspira Pathlab & Diagnostics Limited
Aspira Pathlab & Diagnostics Limited owns, manages, runs, and administers various diagnostics centers primarily in India. The company offers biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigation services. It also provides sonography, x-ray, and radiology tests. The company was formerly known as Utkal Soap Products Limited and changed its name to Aspira Pathlab & Diagnostics Limited in November 2016. Aspira Pathlab & Diagnostics Limited was incorporated in 1973 and is based in Mumbai, India.
- Headquarters
- Mumbai, India
- Promoter Holding
- 91.83%
The full Aspira Pathlab & Diagnostics Limited analysis
Create a free account to open the complete ASPIRA deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.